Clinical Outcomes, Coronary Heart Disease, Drug Therapy, Elderly Patients
Conditions
Brief summary
A registry study on drug therapy and clinical outcomes in elderly patients with coronary heart disease
Interventions
None listed
Sponsors
Beijing Anzhen Hospital
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Informed consent has been signed * Patients diagnosed in our hospital with coronary heart disease * Age ≥65 years
Exclusion criteria
* Severe lack of important information such as history of previous medication, history of previous disease, history of surgery. * Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| main adverse cardiovascular and cerebrovascular events (MACCE) | up to 3 years | MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse drug reaction | up to 3 years | Adverse drug reaction will be defined as any adverse reactions in the patients |
Contacts
Primary ContactYunnan Zhang, PhD
Backup ContactYang Lin, PhD
Outcome results
None listed